Navigation Links
Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
Date:10/21/2010

s tremendous experience to this position," said Craig Tuttle, Transgenomic President and Chief Executive Officer.  "His expertise in genetic test development, combined with his Neuroscience training, will help us build our market leadership position in our Molecular Diagnostics Services business.  We are excited to have him on board."

Commenting on his appointment, Dr. Johnson said, "I am very excited to be joining Transgenomic at such an important inflection point in the company's development. The promise of personalized medicine is becoming a reality in patient care, and I look forward to working with Transgenomic's powerful technologies, COLD-PCR for example, to support the company's goal of being a leader in genetic mutation detection in cancer and neurological diseases."

Dr. Johnson received a B.A. in biology/chemistry from Boston University and a Ph.D. in Neuropharmacology/Neuroscience from the University of Pennsylvania.  He did post-doctoral work in Psychiatry and Neurosurgery at Yale University, and received advanced training genetics at the Jackson Laboratory in Bar Harbor, Maine.

About Transgenomic, Inc.

Transgenomic, Inc. (www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, nearly 1,500 systems have been shipped to customers in more than 50 countries. The SURVEYOR® Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detecti
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell
2. aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
3. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
4. Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research
5. Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
6. Johnson & Johnson Completes Acquisition of Cougar Biotechnology
7. Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
8. Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
9. Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
10. Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
11. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  Having the right people ... vital to accelerating business growth and achieving clinical and ... Association (AHA) Leadership Summit, July 20-22, 2014, in ... of hospital executives and healthcare experts discussing how partnerships ... Carrocino , President & Chief Executive Officer of Cape ...
(Date:7/23/2014)... StemGenex® , the leading resource for ... at improving the lives of patients dealing with degenerative ... disease. StemGenex believes that a commitment to the ... when providing care to patients with degenerative diseases. ... accessible to the millions of individuals currently living with ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... that the anticoagulant Clexane(R) (enoxaparin sodium injection) ... the Ministry of Health, Labour and,Welfare for ... patients,undergoing orthopaedic surgery of the lower limbs ... and hip fracture surgery., Venous thromboembolism ...
... 25 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Healthcare Conference on Wednesday, January 30, at 8:30,a.m. ... webcast of the,presentation at:, http://www.wsw.com/webcast/wa48/onxx/ , ... 15 minutes early in order to,register and download ...
... 0641-2440-45, 0641-2440-41, 0641-2450-45 and 0641-2450-41;, LOTS: 107054, 117085, 047056, 097081, ... ... 107111, DEERFIELD, Ill., Jan. 25 Baxter Healthcare,Corporation has announced the ... 30mL multi-dose vials. The company,began recalling the lots on January 17, 2008 ...
Cached Biology Technology:Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials 2
(Date:7/23/2014)... The U.S. Environmental Protection Agency (EPA) today ... the University of Massachusetts Amherst School of Public ... three-year, $700,000 Science to Achieve Results (STAR) grant ... by Native subsistence hunters in subarctic North America ... exposure and to provide culturally-relevant recommendations for mitigation. ...
(Date:7/23/2014)... fable about the crow and the pitcher, a thirsty bird ... to drink from it, he finds the water level out ... pitcher, the bird drops pebbles into it one at ... him to drink his fill. , Highlighting the value of ... more effective than brute force. It also characterizes crows as ...
(Date:7/23/2014)... Defense recently awarded the STEMPREP Project at Southern ... its goal of increasing the number of minorities ... middle school students for the two-summer classroom phase ... students with summer opportunities at research labs. , ... School of Education and Human Development, boasts an ...
Breaking Biology News(10 mins):Studying impacts of indoor air pollution on tribal communities 2Studying impacts of indoor air pollution on tribal communities 3Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4Department of Defense awards $2.6 million grant to SMU STEM program for minority students 2
... Vein Authentication Technology with, Single-Sign On Solutions Cost-Effectively Bolsters ... ... SUNNYVALE, Calif., Sept. 9 Fujitsu Computer Products of,America, ... disk drives, peripherals and biometric security solutions, today,announced the ...
... Nearly 40 percent of fish species in North American ... to the most detailed evaluation of the conservation status ... The 700 fishes now listed represent a staggering ... in the previous 1989 study published by the American ...
... RUNX3 gatekeeper gene paves the way for the growth and ... issue of the journal Cancer Cell . Previous ... breast, lung and bladder cancers. The inactivation of RUNX3 ... to the Singapore scientists, studies with human tissue samples and ...
Cached Biology News:Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR 2Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR 3Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR 4Silent streams? Escalating endangerment for North American freshwater fish 2Silent streams? Escalating endangerment for North American freshwater fish 3Early stage colon cancer characterized by inactivation of gatekeeper gene 2
... enterprise microarray informatics platform for microarray data storage, ... and use it forever without paying ongoing license ... Acuity has all the analysis tools you need ... quality control statistics and normalization, all the way ...
... industry standard microarray image analysis software because ... analysis tools, visualizations, automation capabilities, performance and ... with every GenePix scanner, and it also ... all types of arrays. A wide range ...
A univariate (peak height or area) quantitative multi-component analysis package....
... H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 (Disulfide ... peptide and 1 ... I-labelled peptide, please see ... ([ 1 2 ...
Biology Products: